BRCA1 mutation in the Triple- Negative Breast Cancer Group

Documenti analoghi

• Prognostic role of BRCA1 mutation in patients with triple-negative breast cancer
  di: MAKSIMENKO, JELENA, et al.
  Pubblicazione: (2014)
• Ultrasound guided needle biopsy of axilla to evaluate nodal metastasis after preoperative systemic therapy in cohort of 106 breast cancers enriched with BRCA1/2 pathogenic variant carriers
  di: Līcīte, Baiba, et al.
  Pubblicazione: (2021)
• Platinum-based neoadjuvant chemotherapy in BRCA1-positive breast cancer: a retrospective cohort analysis and literature review
  di: Sæther, Nikolai Havn, et al.
  Pubblicazione: (2018)
• The difference in contralateral breast cancer and ovarian cancer risks for BRCA1 founder variant (c.5266dup, c.4035del) carriers with primary breast cancer
  di: Peteris Loza, et al.
  Pubblicazione: (2025-11-01)
• High frequency of pathogenic non-founder germline mutations in BRCA1 and BRCA2 in families with breast and ovarian cancer in a founder population
  di: Maksimenko, J., et al.
  Pubblicazione: (2018)